lobbying_activities: 2464345
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2464345 | ce668b1f-1cef-4b94-ad12-59c7702ab495 | Q2 | CRISPR THERAPEUTICS, INC. | 401105184 | CRISPR THERAPEUTICS, INC. | 2020 | second_quarter | PHA | Reimbursement for cell and gene therapies. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 80000 | 0 | 0 | 2020-07-13T15:25:46.660000-04:00 |